AI-driven computational platform for antibody discovery, design, and optimization for biotech and pharma partners.
Macromoltek uses AI and computational modeling to accelerate antibody discovery and engineering for biotech and pharmaceutical partners. The platform supports projects from target identification through lead optimization using proprietary algorithms for epitope mapping, developability assessments, and structural optimization. The company offers flexible partnership models and direct expert collaboration to design antibodies tailored to specific targets, aiming to reduce experimental cycles and time-to-market. Macromoltek is a product of Macromoltek.